Description

Thalidomide CAS NO 50-35-1 is a synthetic glutamic acid derivative with a complex and significant history in pharmaceutical development. Today, it is a critical active pharmaceutical ingredient (API) with established therapeutic applications under strict regulatory control. It is primarily required by pharmaceutical manufacturers and advanced research institutions for the formulation of specific medications and for ongoing biomedical studies. Our supply is characterized by stringent quality assurance, reliable documentation, and consistent purity to meet the exacting demands of modern pharmaceutical production.

Application

• Pharmaceutical API Manufacturing: Primary use as the active ingredient in approved medications for specific conditions, requiring the highest purity and traceability.
• Oncology Research & Drug Development: Investigation into its anti-angiogenic properties for potential cancer therapies and combination treatments.
• Immunomodulatory Therapy: Formulation of treatments for certain autoimmune and inflammatory disorders, leveraging its immunomodulatory effects.
• Dermatology Applications: Research and development for severe dermatological conditions where its mechanism of action is beneficial.
• Reference Standard & Analytical Testing: Serves as a high-purity standard in quality control laboratories for HPLC, LC-MS, and other analytical methods.
• Academic & Clinical Research: Used in controlled studies to understand its pharmacology, teratogenicity mechanisms, and potential new therapeutic windows.

Basic Information

Product Name	Thalidomide
CAS No.	50-35-1
Molecular Formula	C13H10N2O4
Molecular Weight	258.23 g/mol
Synonyms	α-Phthalimidoglutarimide; 2-(2,6-Dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione; N-(2,6-Dioxo-3-piperidyl)phthalimide; Kevadon; Talimol; Distaval; Contergan; Neurosedyn; Sedalis
EINECS	200-031-1

Quality Control

Every batch of our Thalidomide is manufactured and tested under a strict quality management system. We provide comprehensive analytical data to support its use in regulated environments. A detailed Certificate of Analysis (COA) is supplied with each shipment, confirming identity, purity, and the absence of specified impurities. Our quality commitment ensures compliance with the rigorous standards expected for pharmaceutical active ingredients.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability and prevent any potential degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference standard
Identification (HPLC)	Retention time corresponds to reference
Assay (HPLC)	≥ 99.0%
Related Substances (HPLC)	Total impurities ≤ 0.5% Any single unknown impurity ≤ 0.1%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.